Visfatin has been demonstrated to induce proliferation of breast cancer cells proliferation via the extracellular signal-activated kinase (ERK1/2), protein kinase B (AKT), and signal transducer and activator of transcription 3 (STAT3) pathways [3, 4]. This evidence concerns the gene AKT1 and breast carcinoma.